All In Biotech

Drug Trial Radar · NCT07227298

Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

AN INTERVENTIONAL OPEN-LABEL PHASE 1B/2 STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS, AND PRELIMINARY EFFICACY OF PF-08634404 IN COMBINATION WITH DIFFERENT ANTICANCER AGENTS IN PARTICIPANTS WITH ADVANCED SOLID TUMORS

Last checked: Nov 19, 2026Latest source record: Oct 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

162

Planned (sponsor's estimate)

Start

Jan 30, 2026

Primary completion

Mar 8, 2029

Study completion Aug 23, 2033

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
Nov 12, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is being done to learn more about a new medicine called PF-08634404 and how it works when used with other cancer medicines in people who have advanced solid tumors. An advanced solid tumor is a type of cancer that has spread beyond its original location and cannot be removed by surgery or cured with standard treatments. To join in the study, participants must: * Be 18 years or older * Participants with advanced non-small cell lung cancer (NSCLC), a type of lung cancer that has spread to other parts of the body The study will look at: * Whether PF-08634404 is safe to use with other cancer medicines. * What side effects may happen. A side effect is anything the medicine does to your body that is not part of treating your disease. * Whether the combination of PF-08634404 and other cancer medicines can help treat solid tumors. The study has different parts, each testing PF-08634404 with a different cancer medicine: * Part A will test PF-08634404 with a medicine called sigvotatug vedotin. * Part B will test PF-08634404 with a medicine called PF-08046054/SGN-PDL1V Participants will receive the study medicines through an intravenous (IV) infusion (injected into the vein) at the study clinic. All treatments will take place at clinical trial sites, where trained medical staff will monitor participants during and after each visit.

Conditions

  • Advanced/Metastatic Non-Small Cell Lung Cancer
  • Carcinoma, Non-Small Cell Lung
  • Non-Small Cell Lung Cancer

Interventions

  • PF-08634404Biological

    -Concentrate for solution for infusion

  • Sigvotatug VedotinBiological

    -Powder for concentrate for solution for infusion. Single use vial

  • PF-08046054/SGN-PDL1VBiological

    -Powder for concentrate for solution for infusion. Single use vial.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants with Treatment Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)Time frame: Through 90 days after the last study intervention; Up to approximately 5 years
  2. Phase I: Number of participants with dose limiting toxicity (DLT)Time frame: Through 90 days after the last study intervention; Up to approximately 5 years
  3. Phase 2: Confirmed Objective Response Rate (ORR) per RECIST v1.1 by investigatorTime frame: Up to approximately 5 Years

Locations

104 sites in 9 countries. Site status is shown where the registry gives one.

  • Highlands Oncology Group, PA

    Fayetteville, Arkansas · Recruiting

  • Highlands Oncology Group, PA

    Rogers, Arkansas · Recruiting

  • Highlands Oncology Group, PA

    Springdale, Arkansas · Recruiting

  • Providence Medical Foundation

    Fullerton, California · Recruiting

  • Providence St. Jude Medical Center - Virginia K. Crosson Cancer Center and Infusion Center

    Fullerton, California · Recruiting

  • Providence St. Jude Medical Center

    Fullerton, California · Recruiting

  • Scripps Clinic Torrey Pines (Scripps Cancer Center)

    La Jolla, California · Recruiting

  • Scripps Green Hospital

    La Jolla, California · Recruiting

  • Scripps Shiley Pavilion

    La Jolla, California · Recruiting

  • START Los Angeles, LLC

    Los Angeles, California · Recruiting

  • LACN Century City

    Los Angeles, California · Recruiting

  • Valkyrie Clinical Trials (Additional Site Pharmacy Storage Suite)

    Los Angeles, California · Recruiting

  • Valkyrie Clinical Trials (Additional Site Suite)

    Los Angeles, California · Recruiting

  • Valkyrie Clinical Trials

    Los Angeles, California · Recruiting

  • Mission Community Hospital (Satellite Site)

    Panorama City, California · Recruiting

  • Rocky Mountain Cancer Centers,LLP

    Aurora, Colorado · Recruiting

  • Rocky Mountain Cancer Centers,LLP

    Denver, Colorado · Recruiting

  • Rocky Mountain Cancer Centers,LLP

    Lone Tree, Colorado · Recruiting

  • BRCR Medical Center Inc.

    Coral Springs, Florida · Recruiting

  • Moffitt Cancer Center- Speros

    Land O' Lakes, Florida · Not yet recruiting

  • Mid Florida Hematology and Oncology Center

    Orange City, Florida · Recruiting

  • Orlando Health Ambulatory Care Center

    Orlando, Florida · Recruiting

  • Orlando Health Cancer Institute

    Orlando, Florida · Recruiting

  • Orlando Health Orlando Regional Medical Center

    Orlando, Florida · Recruiting

  • Moffitt Cancer Center - SouthShore

    Ruskin, Florida · Not yet recruiting

  • BRCR Global - Tamarac

    Tamarac, Florida · Recruiting

  • Moffitt Cancer Center - International Plaza

    Tampa, Florida · Not yet recruiting

  • Moffitt Cancer Center - McKinley Campus

    Tampa, Florida · Not yet recruiting

  • Moffitt Cancer Center

    Tampa, Florida · Not yet recruiting

  • Moffitt McKinley Hospital

    Tampa, Florida · Not yet recruiting

  • Moffitt Cancer Center - Wesley Chapel

    Wesley Chapel, Florida · Not yet recruiting

  • Hackensack University Medical Center

    Hackensack, New Jersey · Recruiting

  • John Theurer Cancer Center at Hackensack University Medical Center

    Hackensack, New Jersey · Recruiting

  • Newman Street Imaging

    Hackensack, New Jersey · Recruiting

  • John Theurer Cancer Center at JSUMC

    Neptune City, New Jersey · Recruiting

  • Jack & Sheryl Morris Cancer Center

    New Brunswick, New Jersey · Not yet recruiting

  • Robert Wood Johnson University Hospital (RWJBH)

    New Brunswick, New Jersey · Not yet recruiting

  • Robert Wood Johnson University Hospital

    New Brunswick, New Jersey · Not yet recruiting

  • Rutgers Cancer Institute

    New Brunswick, New Jersey · Not yet recruiting

  • John Theurer Cancer Center at From Road

    Paramus, New Jersey · Recruiting

Showing 40 of 104 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.